Published September 1, 2025 | Version v1
Journal article Open

A VALIDATED RP-HPLC METHOD FOR ESTIMATION OF DAPAGLIFLOZIN IN BULK AND TABLET DOSAGE FORM

Authors/Creators

  • 1. 12nd Year M Pharma, Student of Department of Pharmaceutical Analysis, Bharathi College of Pharmacy, Bharathinagara, Mandya, Karnataka, India -571422.
  • 2. 2Professor and HOD of Department of Pharmaceutical Analysis, Bharathi College of Pharmacy, Bharathinagara, Mandya District, Karnataka, India -571422.
  • 3. 3Assistant Professor, Department of Pharmaceutical Analysis, Bharathi College of Pharmacy, Bharathinagara, Mandya District, Karnataka, India -571422.

Description

A simple, rapid, precise, sensitive and reproducible reverse phase high performance liquid chromatography (RP-HPLC) method has been developed for the quantitative analysis of Dapagliflozin in pharmaceutical dosage form. Chromatographic separation of Dapagliflozin was achieved on Prominence LC-20A Quaternary Gradient HPLC system, by using Shimpack C-18 (5μm, 4.6 x 250mm) column and the mobile phase containing Methanol and water with 0.1% ortho phosphoric acid with pH of 4.5 in a 80:20v/v ratio. The flow rate was 1.0ml/min; detection was carried out by absorption at 224nm using a UV detector at ambient temperature. LOD and LOQ were found to be 1.279 μg/ml and 3.877 μg/ml respectively and retention time was found to be 3.935mins. The % Recovery was found to be 99.93%-100.29%. The number of theoretical plates and tailing factor for Dapagliflozin were not less than 2000 and not more than 2 respectively. % Relative standard deviation of peak areas of all measurements always less than 2.0. The proposed method was validated according to ICH guidelines. The method was found to be simple, economical, suitable, precise, accurate and robust method for quantitative analysis of Dapagliflozin.

Files

25 WJAPS 242.pdf

Files (348.4 kB)

Name Size Download all
md5:885136e0640ec821a7ffe10fae180504
348.4 kB Preview Download

Additional details

Identifiers

ISSN
3049-3013

Related works

Is referenced by
Journal article: 3049-3013 (ISSN)

References

  • Al-Arjani RA. Development and Validation of a New Combination: Dapagliflozin, Pioglitazone and Metformin Simultaneously in Tablets Dosage Form by HPLC. Master's thesis, University of Petra., Aug 2021; 9-24.
  • Padmaja BR, Sivagami B, Chandrasekar R, Babu MN. A highly validated RP-HPLC method development for the simultaneous estimation of dapagliflozin and saxagliptin in tablet dosage forms. Int J Pharm Sci Drug Res., 2018 sep-oct; 10(5): 372-8.
  • Mante GV, Gupta KR, Hemke AT. Estimation of dapagliflozin from its tablet formulation by UV-spectrophotometry. Pharm Methods, 2017 Jul 1; 8(2): 102-7.
  • V.B. Tambe, P.S. Tajane, R. K. Godge. Analytical method Development and Validation of Dapagliflozin by UV-spectroscopy. IJFANS Intl J of Food and Nutritional Sci., 2022; 11(11): 709-716.
  • Yadav M, Chauhan R, Singh R, Tiwari N. UV-Spectrophotometric Approach for Concurrent Assessment of Sitagliptin and Dapagliflozin. Afr. J. Bio. Sc., 2024 Apr 22; 6(9): 1024-1032.
  • Suthar AM, Prajapati LM, Joshi AK, Patel JR, Kharodiya ML. Estimation of Saxagliptin hydrochloride and Dapagliflozin propendiol monohydrate in combined dosage form. J. of Innv in Appl Pharm Sci (JIAPS)., 2018 Jun 30; 3(2): 01-7.
  • Patel A, Omray DL, Soni P. Method development for simultaneous estimation of Dapagliflozin and saxagliptin in fixed-dose combination and validation on UV spectroscopy. J Pharm., 2020; 9(3): 2536-43.
  • Minal H, Sameer L, Valmik G, Vitthal C, Khomne A. Ultraviolet-spectrophotometric method for simultaneous estimation of Dapagliflozin propanediol and Metformin hydrochloride. Intl Res J of Pharm., 2019; 10(4): 90-4.
  • Patel M, Vyas N, Shah H, Shah U, Patel A, Chokshi A. Analytical methods for simultaneous estimation of SGLT2 inhibitor and DPP-4 inhibitor in their combination for treatment of type 2 diabetes mellitus. Lett Appl Nano Bio Science, 2020; 10(1): 1799-815.
  • Mahabole S, Gajeli G, Kalshetti M. RP-HPLC and UV Spectroscopic Method Development and Validation for Estimation of Dapagliflozin in Bulk and Pharmaceutical Dosage Form. Research Sqare, 2024 jun 12; 2-15.
  • Borse LB, Wagh MS, Borse SL, Ahire SP, Vaishnav IS, Naphade VD, Gulecha VS. RP-HPLC Method Development And Validation For Estimation Of Dapagliflozin In Tablet Formulation. J of Pharm Negative Results, 2022 Oct 15; 13(5): 364-72.
  • Mante GV, Hemke AT, Umekar MJ. RP-HPLC method for estimation of dapagliflozin from its tablet. Intl J of Chem Tech Res., 2018; 11(01): 242-8.
  • Gaikwad AV, Gawade AS, Hupparage Vrushabh B, Mantry S, Kale A, Kale J. Method Development and Validation of Dapagliflozin by RP-HPLC. Jl of Pharm Negative Results, 2022 Dec 31; 13(6): 4316-35.
  • Sree VN, Bhavyasri DK, Sumakanth DM, Swethasri R. Estimation of Dapagliflozin in Pure and Marketed Formulation by Validated Reverse Phase-High Performance Liquid Chromatographic Method. (2020). Int. J. Life Sci. Pharma Res., 10(4): P70-84.
  • Sravanthi S, Zarin N, Shruthi B, Krishna DR, Manjeera A. A New Analytical Method Development and Validation for the Estimation of Dapagliflozin by Using Reverse Phase-High Performance Liquid Chromatography. Intl J of adv res in medical pharm sci., jul 2021; 6(4): 13-20.
  • Debata J, Kumar S, Jha SK, Khan A. A New RP-HPLC method development and validation of dapagliflozin in bulk and tablet dosage form. Int J Drug Dev Res., 2017; 9(2): 48-51.
  • Pal N, Mahtab T, Reddy PP, Rao AS.A new HPLC method development and validation for the determination of dapagliflozin in tablet dosage form. World J of pharma res., 2019; 8(9): 1156-1165.
  • Urooj A, Sundar PS, Vasanthi R, Raja MA, Dutt KR, Rao KN, Ramana H. Development and validation of RP-HPLC method for simultaneous estimation of dapagliflozin and metformin in bulk and in synthetic mixture. World J Pharm Pharm Sci., 2017 May 20; 6(7): 2139-50.
  • Rao BR, Rao VV, Venkateswarlu BS. RP-HPLC method for simultaneous estimation of dapagliflozin and saxagliptin in bulk samples. J of Pharm Sci and Res., 2019; 11(1): 254-7.
  • Bhavyasri K, Surekha T, Begum S, Sumakanth M. RP-HPLC Method for Dapagliflozin and Metformin HCL in Bulk and Combined Formulation. Archives of Pharmacy Practice, 2021; 12(4-2021): 106-10.
  • Kladi E, Zerva M, Dotsikas Y. A novel HPLC method for the simultaneous determination of empagliflozin and dapagliflozin: Development, validation, robustness testing and greenness assessment. Archives of Pharmacy, 2024 Apr 28; 74(Notebook 2): 267-80.
  • Suma BV, Deveswaran R, Premnath SH. A new high-performance thin layer chromatographic method development and validation of dapagliflozin in bulk and tablet dosage form. Int J Pharm Pharm Sci., 2019 Aug 1; 11(8): 58-63.
  • Madhavi S, Rani AP. Development and validation of a method for simultaneous determination of dapagliflozin and saxagliptin in a formulation by RP-UPLC. World J Pharma Res., 2017 Aug 11; 6(12): 904-16.
  • ICH, Q2A text on validation of analytical procedures, 1994.
  • ICH, Q2B validation of analytical methodology, 1996.
  • ICH, Q2 (R1) validation of analytical procedures: text and methodology, 2005.